pharmaceutical companies News

Rickitt to Pay $1.4B to End U.S. Opioid Addiction Probe

Reckitt Benckiser has agreed to pay up to $1.4 billion to resolve U.S. claims that its former pharmaceuticals business Indivior before it was spun out of the company carried out an illegal scheme to boost sales of an opioid addiction …

Overdose Victim’s Father Testifies in Oklahoma Opioid Trial of J&J

The father of a university football player who died of a drug overdose provided emotional testimony about the personal cost of the nationwide opioid epidemic on Wednesday during the second day of trial in a lawsuit by the state of …

Teva Is at Center of Drug Price-Fixing Case Filed by States

Teva Pharmaceutical Industries Ltd. helped mastermind a sweeping conspiracy among generic-drug makers to raise the price of medicines, according to a new antitrust lawsuit filed by states that stems from a five-year investigation of the companies. Teva’s stock fell. More …

Drug Middlemen Face State Probes Over Complex Pricing System

Several states are probing pharmacy-benefit managers’ business practices in government-sponsored health programs, adding to the scrutiny the middlemen face in Washington for their role in the cost of drugs. At least three state attorneys general are investigating PBMs, in addition …

N.Y. Accuses Opioid Maker Purdue of Illegal Fund Transfers to Sacklers

Purdue Pharma LP fraudulently transferred funds to members of the wealthy Sackler family who control the OxyContin maker despite knowing it faced major liabilities that had made it already insolvent, New York’s attorney general alleged on Thursday. New York Attorney …

Tainted Pills Force FDA to Tighten Drug-Safety Regulations

U.S. regulators plan to revamp rules governing how medicines are manufactured, in an effort to ensure the safety of the nation’s drug supply as recalls of contaminated imports from developing countries widen. “We’ve seen a lot of instances of adulterated …

Wearables Being Used by Big Pharma to Collect Better Personal Data

Pharmaceutical companies are enlisting Fitbits and other gadgets strapped to patients’ wrists, chests and skin as a way to bring drugs to market faster. What began as an aid for athletes and dieters to track their movements is quickly becoming …